Investment giants join forces to form largest healthcare firm on the globe
Two key healthcare investors have merged to create the largest dedicated investment manager in their specialist sector, which will see…
20 May 2026
Clinical Trials Day 2026: ‘Research Rising’ theme reflected in Q1 study growth
As 20 May marks Clinical Trials Day 2026, the ‘Research Rising’ theme has never seemed so apt, as trial initiations in Q1 2026 saw an uptick, with key R&D player…
20 May 2026
Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict
Takeda has been ordered to pay $885m – potentially rising to $2.5bn – after a landmark court case verdict found the Japanese pharma company liable for a conspired arrangement to…
20 May 2026
QIAGEN and NVIDIA partner on AI drug discovery
QIAGEN’s Digital Insights bioinformatics division is set to integrate NVIDIA’s accelerated computing and the BioNeMo platform to enhance AI-driven drug discovery. The move aims to allow pharmaceutical and biotechnology researchers…
20 May 2026
SERB signs agreement to acquire Idefirix rights for $133.6m
SERB Pharmaceuticals has signed an agreement to acquire exclusive development and commercialisation rights to Idefirix (imlifidase) from Hansa Biopharma for a total of €115m ($133.6m). The deal covers the European…
19 May 2026
UK government bolsters antiviral supply for hantavirus
The UK has received doses of antiviral medicine favipiravir as a precaution in case hantavirus spreads in the country. The medicine, developed by Fujifilm subsidiary Toyama Chemical in Japan, has…
19 May 2026
VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain
VERTANICAL has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for VER-01, its investigational non-opioid treatment for chronic low back pain. The designation follows two randomised,…